Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research
- PMID: 28787275
- DOI: 10.1515/revneuro-2017-0011
Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research
Abstract
Multiple sclerosis (MS) is a chronic, progressive disease of the central nervous system that is characterised by inflammatory damage to the myelin sheath. Though often neglected, cognitive impairment is a common feature of MS that affects 43-70% of patients. It has a sophisticated neuroanatomic and pathophysiologic background and disturbs such vital cognitive domains as speed of information processing, memory, attention, executive functions and visual perceptual functions. In recent years there has been growing interest in neuroimaging findings with regard to cognitive impairment in MS. The possible options of managing cognitive dysfunction in MS are pharmacologic interventions, cognitive rehabilitation and exercise training; however, not enough evidence has been presented in this field. The aim of our article is to provide current knowledge on cognitive impairment in MS based on the most recent scientific results and conclusions with regard to affected cognitive domains, neuropsychological assessment, underlying mechanisms of this disturbance, neuroimaging findings and therapeutic options.
Keywords: cognitive dysfunction; executive functions; memory; neuroimaging; neuropsychological assessment.
Similar articles
-
Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis.Curr Neuropharmacol. 2018;16(4):475-483. doi: 10.2174/1570159X15666171109132650. Curr Neuropharmacol. 2018. PMID: 29119933 Free PMC article. Review.
-
Neuroimaging and genetic correlates of cognitive dysfunction in multiple sclerosis.Psychiatr Pol. 2015;49(5):897-910. doi: 10.12740/PP/32182. Psychiatr Pol. 2015. PMID: 26688841 Review. English, Polish.
-
Impact of physical activity, physical fitness and exercises on cognitive impairment in patients with multiple sclerosis: A review of evidence and underlying mechanisms.Rev Neurol (Paris). 2024 Sep;180(7):583-598. doi: 10.1016/j.neurol.2023.06.003. Epub 2023 Oct 3. Rev Neurol (Paris). 2024. PMID: 37798163 Review.
-
Sleep Disturbance and Cognitive Dysfunction in Multiple Sclerosis: a Systematic Review.Curr Neurol Neurosci Rep. 2018 Jan 29;18(1):2. doi: 10.1007/s11910-018-0809-7. Curr Neurol Neurosci Rep. 2018. PMID: 29380072
-
Differential diagnosis, discerning depression from cognition.Acta Neurol Scand. 2016 Sep;134 Suppl 200:14-8. doi: 10.1111/ane.12652. Acta Neurol Scand. 2016. PMID: 27580901 Review.
Cited by
-
Social Cognition in Multiple Sclerosis: A 3-Year Follow-Up MRI and Behavioral Study.Diagnostics (Basel). 2021 Mar 9;11(3):484. doi: 10.3390/diagnostics11030484. Diagnostics (Basel). 2021. PMID: 33803307 Free PMC article.
-
Contribution of Gray Matter Atrophy and White Matter Damage to Cognitive Impairment in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients.Diagnostics (Basel). 2021 Mar 23;11(3):578. doi: 10.3390/diagnostics11030578. Diagnostics (Basel). 2021. PMID: 33807060 Free PMC article.
-
Potentials and barriers of using digital tools for collecting daily measurements in multiple sclerosis research.Digit Health. 2021 Nov 26;7:20552076211055552. doi: 10.1177/20552076211055552. eCollection 2021 Jan-Dec. Digit Health. 2021. PMID: 35173979 Free PMC article.
-
Biochanin A Improves Memory Decline and Brain Pathology in Cuprizone-Induced Mouse Model of Multiple Sclerosis.Behav Sci (Basel). 2022 Mar 4;12(3):70. doi: 10.3390/bs12030070. Behav Sci (Basel). 2022. PMID: 35323389 Free PMC article.
-
Impact of depression on the perception of fatigue and information processing speed in a cohort of multiple sclerosis patients.BMC Psychol. 2023 Jul 14;11(1):208. doi: 10.1186/s40359-023-01235-x. BMC Psychol. 2023. PMID: 37452373 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical